BioAdaptives Ownership
| BDPT Stock | USD 0.13 0.03 30.00% |
BioAdaptives |
BioAdaptives Pink Sheet Ownership Analysis
The company recorded a loss per share of 0.02. BioAdaptives had not issued any dividends in recent years. BioAdaptives, Inc. markets and distributes natural plant and algal-based products for humans and animals. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada. Bioadaptives operates under Packaged Foods classification in the United States and is traded on OTC Exchange. It employs 3 people.The quote for BioAdaptives is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on BioAdaptives please contact MD Jacobs at 702 659 8829 or go to https://www.shopbioadaptives.com.BioAdaptives Outstanding Bonds
BioAdaptives issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. BioAdaptives uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most BioAdaptives bonds can be classified according to their maturity, which is the date when BioAdaptives has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for BioAdaptives Pink Sheet Analysis
When running BioAdaptives' price analysis, check to measure BioAdaptives' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAdaptives is operating at the current time. Most of BioAdaptives' value examination focuses on studying past and present price action to predict the probability of BioAdaptives' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAdaptives' price. Additionally, you may evaluate how the addition of BioAdaptives to your portfolios can decrease your overall portfolio volatility.